115 related articles for article (PubMed ID: 2636819)
1. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
Coruzzi G; Adami M; Bertaccini G
Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
[TBL] [Abstract][Full Text] [Related]
2. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
Holtmann G; Küppers U; Singer MV
Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
[TBL] [Abstract][Full Text] [Related]
3. Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding.
Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Kromer W
Digestion; 1989; 44(2):66-78. PubMed ID: 2575551
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
Digestion; 1988; 40(1):25-32. PubMed ID: 3234616
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the inhibitory effect of three antimuscarinic drugs: pirenzepine, atropine and propantheline on acid secretion and gastric emptying in the conscious rat.
Rodríguez C; Martí-Bonmati E; Esplugues JV; Brage R; Esplugues J
Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):403-6. PubMed ID: 3762265
[TBL] [Abstract][Full Text] [Related]
7. An acid-independent antiulcer effect of M1 antimuscarinics in the rat.
Kromer W; Gönne S
Pharmacology; 1988; 37 Suppl 1():48-53. PubMed ID: 3237766
[TBL] [Abstract][Full Text] [Related]
8. Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.
Londong W; Londong V; Meierl A; Voderholzer U
Gut; 1987 Jul; 28(7):888-95. PubMed ID: 3653758
[TBL] [Abstract][Full Text] [Related]
9. Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
Singer MV; Teyssen S; Küppers U
Digestion; 1991; 48(1):34-42. PubMed ID: 1868967
[TBL] [Abstract][Full Text] [Related]
10. A comparison of pirenzepine and cimetidine inhibition of centrally-mediated gastric acid and pepsin secretion in the gastric-fistula cat.
Browning JG; Heathcote BV
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):288-96. PubMed ID: 6411019
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells.
Kromer W; Baron E; Beinborn M; Eltze M; Simon WA
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):68-75. PubMed ID: 2477717
[TBL] [Abstract][Full Text] [Related]
12. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
13. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal activities of a new pirenzepine-analog, nuvenzepine, in the cat.
Barocelli E; Chiavarini M; Gentile A; Lavezzo A; Impicciatore M
Farmaco; 1990 Oct; 45(10):1089-99. PubMed ID: 2095154
[TBL] [Abstract][Full Text] [Related]
15. Effects of atropine and pirenzepine on healing of gastric ulcer induced by mucosal excision in rats.
Sano M; Kitagawa H; Fujiwara M
Clin Ther; 1985; 7(3):380-9. PubMed ID: 3838920
[TBL] [Abstract][Full Text] [Related]
16. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors.
Poli E; Monica B; Zappia L; Pozzoli C; Bertaccini G
Gen Pharmacol; 1992 Jul; 23(4):659-64. PubMed ID: 1397972
[TBL] [Abstract][Full Text] [Related]
17. Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia.
Galvan M; Boer R; Schudt C
Eur J Pharmacol; 1989 Aug; 167(1):1-10. PubMed ID: 2776837
[TBL] [Abstract][Full Text] [Related]
18. Influence of "selective" antimuscarinic agents on gastric acid secretion and motility.
Subissi A; Guelfi M; Maggi CA; Meli A
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):313-9. PubMed ID: 3161479
[TBL] [Abstract][Full Text] [Related]
19. Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells.
Schmid SW; Modlin IM; Tang LH; Stoch A; Rhee S; Nathanson MH; Scheele GA; Gorelick FS
Am J Physiol; 1998 Apr; 274(4):G734-41. PubMed ID: 9575856
[TBL] [Abstract][Full Text] [Related]
20. The affinity, selectivity and biological activity of telenzepine enantiomers.
Schudt C; Boer R; Eltze M; Riedel R; Grundler G; Birdsall NJ
Eur J Pharmacol; 1989 Jun; 165(1):87-96. PubMed ID: 2475354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]